FDA approves Eucrisa ointment to treat eczema

The US Food and Drug Administration (FDA) has approved Anacor Pharmaceuticals ’ Eucrisa (crisaborole) ointment for the treatment of mild-to-moderate eczema (atopic dermatitis) in patients aged two and older.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news